Luisa Sánchez-Lorenzo

7PUBLICATIONS
50CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 18, 2024
Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial.

Antonio González-Martín, María Jesús Rubio, Florian Heitz

|Aug 17, 2024
SENECA study: staging endometrial cancer based on molecular classification.

Enrique Chacon, Felix Boria, R Rajagopalan Lyer

|Mar 13, 2024
An international worldwide retrospective cohort observational study comparing primary cytoreductive surgery with neoadjuvant chemotherapy and interval cytoreductive surgery in patients with carcinoma of the ovary, fallopian tubes, and peritoneum (SUROVA trial).

Luis Chiva, Pilar Ordás, Nerea Martin-Calvo

|Mar 10, 2022
The BRCA Gene in Epithelial Ovarian Cancer.

Luisa Sánchez-Lorenzo, Diego Salas-Benito, Julia Villamayor

Pageof 2